Monoclonal Antibodies for COVID-19 in Children: Case Series Should be Just the Start
- PMID: 36928718
- DOI: 10.1093/jpids/piad006
Monoclonal Antibodies for COVID-19 in Children: Case Series Should be Just the Start
Abstract
Two new articles describe the use and implementation of monoclonal antibodies to treat COVID-19 in children. While these studies provide valuable guidance for pediatric clinicians, more studies of monoclonal antibodies and other COVID-19 therapies in children are needed.
Keywords: COVID-19; SARS-CoV-2; monoclonal antibodies; pediatric.
© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Comment on
-
Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.J Pediatric Infect Dis Soc. 2023 Apr 18;12(3):152-155. doi: 10.1093/jpids/piac124. J Pediatric Infect Dis Soc. 2023. PMID: 36928172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
